Contrast Imaging (Toshiba PowerVision 8000 and Aplio)

  • Masatoshi Kudo


Remarkable progress has been made in contrast-enhanced ultrasonography (US) over the last 10 years since research began on harmonic imaging based on the nonlinear phenomenon of microbubbles following the development of intravenously administered ultrasonic contrast agents.1 At present, ten types of ultrasonic contrast agents are in development and various combinations of contrast agent and imaging technique are now being studied to determine which of them provides the most useful diagnostic findings. This chapter describes the optimal contrast mode of the PowerVision series for contrast imaging, mainly using Levovist. The features of next-generation contrast agents are also described with regard to both engineering and clinical practice.


Contrast Agent Mechanical Index High Frame Rate Transmission Interval Blood Flow Signal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schrope B, Newhouse VL, Uhlendorf V, et al: Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging 1992; 14:134–158PubMedCrossRefGoogle Scholar
  2. 2.
    Burns PN, Wilson SR, Simpson DH: Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35(1):58–71PubMedCrossRefGoogle Scholar
  3. 3.
    Kamiyama N, Moriyasu F, Mine Y, et al: Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 1999; 25:411–420PubMedCrossRefGoogle Scholar
  4. 4.
    Dayton PA, Morgan KE, Lum AF, et al: Optical and acoustical observations of the effects of ultrasound on contrast agent. Biophy J 2001; 80:1547–1556CrossRefGoogle Scholar
  5. 5.
    Ding H, Kudo M, Onda H, et al: Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220:349–356PubMedGoogle Scholar
  6. 6.
    Ding H, Kudo M, Onda H,et al: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR 2001; 176:661–666PubMedGoogle Scholar
  7. 7.
    Ding H, Kudo M, Onda H, etal: Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 2001; 29:411–416PubMedCrossRefGoogle Scholar
  8. 8.
    Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepato-Gastroenterology 1998; 45:1226–1231PubMedGoogle Scholar
  9. 9.
    Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297–309PubMedCrossRefGoogle Scholar
  10. 10.
    Kudo M: Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62(Suppl l):48–56PubMedCrossRefGoogle Scholar
  11. 11.
    Kudo M: Contrast harmonic ultrasound is a breakthrough technology in the diagnosis and treatment of hepatocellular carcinoma. J Med Ultrasonics 2001; 28:79–81CrossRefGoogle Scholar
  12. 12.
    Wen YL, Kudo M, Minami Y, et al: Detection of tumor vascularity in hepatocellular carcinoma with contrast enhanced Dynamic Flow imaging: comparison with contrast enhanced power Doppler imaging. J Med Ultrasonics 2003 (in press)Google Scholar
  13. 13.
    Wen YL, Kudo M, Maekawa K, et al: Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: preliminary results in hepatic tumors. J Med Ultrasonics 2002; 29:195–204CrossRefGoogle Scholar

Copyright information

© Springer Japan 2003

Authors and Affiliations

  • Masatoshi Kudo
    • 1
  1. 1.Department of Gastroenterology and HepatologyKinki University School of MedicineOsakaJapan

Personalised recommendations